相关实验视频

Updated: Jun 29, 2025

Peptide-based Identification of Functional Motifs and their Binding Partners

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

针对HIV-1的基于6-HB核心结构的短融合抑制剂的研究策略:一篇评论

Guodong Liang¹, Yan Huang¹, Yanbai Tang¹

¹Key Laboratory for Candidate Drug Design and Screening Based on Chemical Biology, College of Pharmacy, Inner Mongolia Medical University, Huhhot, 010110, P.R. China.

Current pharmaceutical biotechnology

|March 29, 2024

概括

新型短是一种有希望的解决方案,可以克服当前人类免疫缺陷病毒1型 (HIV-1) 融合抑制剂,如恩福维 (T20) 的局限性. 这些具有高耐药性障碍和改善的药理动力学特性,可有效治疗获得性免疫缺陷综合征 (AIDS).

科学领域:

病毒学病毒学
药物发现药物发现药物发现
药用化学医学化学

背景情况:

获得性免疫缺陷综合征 (艾滋病) 是由人类免疫缺陷病毒1型 (HIV-1) 引起的.
恩福维 (T20) 是第一个在市场上销售的HIV-1融合抑制剂,对艾滋病治疗至关重要.
T20表现出局限性,包括快速耐药性,体内半衰期短,清除快,阻碍其临床使用.

研究的目的:

审查针对针对HIV-1的新型短基融合抑制剂的新兴研发 (R&D) 策略.
解决与T20等现有融合抑制剂相关的缺陷.
探索短在克服HIV-1融合抑制当前挑战的潜力.

主要方法:

对基于短的HIV-1融合抑制剂的六种新兴研发策略的摘要.
对延长半衰期和抗药性耐药性的改的分析.
专注于共同的膜融合六螺旋捆 (6-HB) 核心结构.

主要成果:

短可以进行修改,以获得更长的半衰期和更高的耐药性障碍.
新兴的战略重点是开发新的短融合抑制剂.
预计这些可以克服T20的限制.

结论:

基于短的融合抑制剂是开发下一代抗HIV-1疗法的有希望的途径.
修改后的短提供了改善的药物动力学特征和抗药性.
本综述为开发使用6-HB结构的新型HIV-1融合抑制剂和潜在的其他病毒融合抑制剂提供了洞察力.

关键词:

6-HB 6HB 的使用方法人类健康委员会 (CHR)艾滋病病毒-1 艾滋病病毒-1 聚变抑制剂聚变抑制剂研究战略研究策略研究策略简短的. 短的.

更多相关视频

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

Published on: August 14, 2018

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

相关概念视频

Peptide Bonds

Peptide Bonds

A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Retroviruses

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...